Bimekizumab, recognized by its chemical code THPTA 1418205-77-2, constitutes a novel therapeutic approach within the interleukin (IL)-17 family of medicines . This pharmaceutical compound acts as a specific https://www.targetmol.com/compound/bimekizumab